Section Arrow
EDSA.NASDAQ
- Edesa Biotech
Quotes are at least 15-min delayed:2025/06/02 13:45 EDT
Last
 1.99
+0.03 (+1.53%)
Day High 
2.0074 
Prev. Close
1.96 
1-M High
2.4 
Volume 
13.45K 
Bid
1.97
Ask
2.01
Day Low
1.9369 
Open
1.96 
1-M Low
1.88 
Market Cap 
13.76M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA
20-SMA 2.08 
50-SMA 2.25 
52-W High 5.59 
52-W Low 1.55 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.55/-0.56
Enterprise Value
13.76M
Balance Sheet
Book Value Per Share
0.90
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OGENOragenics0.1796+0.0596+49.67%-- 
PSTVPlus Therapeutics0.5329+0.246+85.74%-- 
PCSAProcessa Pharmaceuticals0.3015+0.009+3.08%-- 
IRDOpus Genetics Inc1.18+0.1855+18.65%-- 
BPMCBlueprint Medicines Corp127.675+26.325+25.97%-- 
Quotes are at least 15-min delayed:2025/06/02 13:45 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.